Wainwright et al. showed therapeutic inhibition of IDO, CTLA-4, and PD-L1 in a mouse model of well-established glioma maximally decreases tumor-infiltrating T-regs, coincident with a significant increase in T-cell-mediated long-term survival (40). This evidence concerns the gene IDO1 and neoplasm.